THERAPEUTIC CLAIM: Advanced Gastrointestinal Stromal Tumor (GIST)
CHEMICAL NAMES: N-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N’-phenylureaUrea, N-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N’-phenyl-
MOLECULAR FORMULA: C24-H21-Br-F-N5-O2
MOLECULAR WEIGHT:     510.364
TRADEMARK:                     QINLOCK
SPONSOR:                            Deciphera Pharmaceuticals, Inc
CODE DESIGNATIONS:      DCC-2618
CAS REGISTRY NUMBER: 1442472-39-0
UNII:                                       9XW757O13D
SPECIAL DESIGNATIONS: Priority Review, Fast Track, Breakthrough Therapy, Orphan Drug
PATENT EXPIRY: US 1st Patent Expiry on 2027
DOSAGE FORM: Tablet
For other information regarding deals and geographical patents write to us or contact us at pharmainxight@gmail.com

Source: FDA

By demo1

Leave a Reply

Your email address will not be published. Required fields are marked *